FairScope Lab
EN 繁中 简中

BIIB

Valuation Healthcare · Drug Manufacturers - General Data as of 2026-06-30

P/E Ratio · Metrics

P/E Ratio

82.38

PEG Ratio

-

Dividend Yield

-

Gross Margin

56.92%

Net Margin

3.56%

Revenue CAGR 3Y

3.66%

ROE

2.07%

ROA

1.22%

Buyback Yield

-0.20%

Current Ratio

1.87

Magic Earn Yield

2.19%

Altman Z-Score

2.61

Fair Value River

Score

Valuation 7
Profitability 18
Growth 12
Health 57
Yield 0
← Back to Dashboard